CD130/gp130 抗体
Quick Overview for CD130/gp130 抗体 (ABIN1383678)
抗原
See all CD130/gp130 (IL6ST) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            特异性
- Recognises the Gp130, common subunit for IL-6, IL-11, OSM, LIF, CNTF, CT-1 receptors, a 130-140 kDa protein
- 
                                            纯化方法
- Ion exchange chromatography
- 
                                            过滤
- 0.22 μm filtered
- 
                                            免疫原
- Natural soluble gp130,Myeloma X63/AG.8653 x Balb/c spleen cells
- 
                                            亚型
- IgG2a, kappa
- 
                                            Biological Activity Comment
- Inhibits IL-6, IL-11, CNTF, LIF and OSM activities
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- 
                                            储存液
- Without preservative
- 
                                            储存条件
- 4 °C
- 
                                            储存方法
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
 
- 
                                            
- 
    - 
                                            : "Akt signaling pathway: a target for radiosensitizing human malignant glioma."    in: Neuro-oncology, Vol. 12, Issue 5, pp. 434-43, (2010)         (PubMed).        
 : "N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130." in: The Journal of biological chemistry, Vol. 285, Issue 3, pp. 1781-9, (2010) (PubMed).
 : "In vivo modulation of soluble \" IL-6 receptor synthesis and release in ESRD." in: Journal of the American Society of Nephrology : JASN, Vol. 16, Issue 4, pp. 1099-107, (2005) (PubMed).
 : "Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II." in: Endocrinology, Vol. 144, Issue 12, pp. 5381-9, (2003) (PubMed).
 : "Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 16, Issue 13, pp. 1799-801, (2002) (PubMed).
 : "Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma." in: The hematology journal : the official journal of the European Haematology Association / EHA, Vol. 2, Issue 1, pp. 42-53, (2002) (PubMed).
 : "STAT3 is constitutively activated in Hodgkin cell lines." in: Blood, Vol. 98, Issue 3, pp. 762-70, (2001) (PubMed).
 : "Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus." in: Blood, Vol. 98, Issue 10, pp. 3042-9, (2001) (PubMed).
 : "Identification of a gp130 cytokine receptor critical site involved in oncostatin M response." in: The Journal of biological chemistry, Vol. 275, Issue 8, pp. 5648-56, (2000) (PubMed).
 : "Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors." in: Leukemia, Vol. 14, Issue 1, pp. 188-97, (2000) (PubMed).
 : "Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies." in: The Journal of biological chemistry, Vol. 275, Issue 7, pp. 4579-86, (2000) (PubMed).
 : "Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction." in: The Journal of biological chemistry, Vol. 274, Issue 35, pp. 24685-93, (1999) (PubMed).
 : "Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway." in: The Biochemical journal, Vol. 330 ( Pt 1), pp. 47-54, (1998) (PubMed).
 : "Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties." in: FEBS letters, Vol. 407, Issue 2, pp. 141-7, (1997) (PubMed).
 : "Signaling of type II oncostatin M receptor." in: The Journal of biological chemistry, Vol. 272, Issue 25, pp. 15760-4, (1997) (PubMed).
 : "Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M." in: Journal of immunological methods, Vol. 190, Issue 1, pp. 21-7, (1996) (PubMed).
 : "Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein." in: The Journal of biological chemistry, Vol. 271, Issue 25, pp. 14764-72, (1996) (PubMed).
 : "Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop." in: Blood, Vol. 88, Issue 10, pp. 3972-86, (1996) (PubMed).
 
 
- 
                                            : "Akt signaling pathway: a target for radiosensitizing human malignant glioma."    in: Neuro-oncology, Vol. 12, Issue 5, pp. 434-43, (2010)         (PubMed).        
- 
    - CD130/gp130 (IL6ST) (Interleukin 6 Signal Transducer (Gp130, Oncostatin M Receptor) (IL6ST))
- 
                                            别名
- CD130
- 
                                            背景
- Gp130
- 
                                            分子量
- 130-140 kDa
- 
                                            途径
- JAK/STAT Signaling, Cellular Glucan Metabolic Process, Autophagy, Smooth Muscle Cell Migration, Cancer Immune Checkpoints
 抗原
- 
                    
 
                                     
                                     
                                    